In the News April 20, 2015

Cathy Burgess Discusses Recent FDA Enforcements with The Gray Sheet (Audio)

Cathy Burgess, partner in Alston & Bird’s Health Care Group, addressed recent FDA enforcement actions on data-integrity issues during a panel discussion at the Food and Drug Law Institute. Burgess spoke with The Gray Sheet about the need for more FDA guidance on controls. Listen here.
Media Contact
Nicholas Clarke
Senior Communications Manager
Phone: 212.210.1222
This website uses cookies to improve functionality and performance. By continuing to browse this site, you are consenting to the use of cookies on this website. For details, see our Privacy Statement